Issues of bioequivalence and cost equivalence.
Al-Inany
Hesham G
HG
D003362:Cost-Benefit Analysis; D005307:Fertilization in Vitro / Q000191:economics*; D005640:Follicle Stimulating Hormone / Q000191:economics* / Q000493:pharmacokinetics / Q000652:urine*; D043373:Follicle Stimulating Hormone, Human; D006801:Humans; D011994:Recombinant Proteins / Q000191:economics* / Q000493:pharmacokinetics; D020554:Sperm Injections, Intracytoplasmic / Q000191:economics; D013810:Therapeutic Equivalency; D014481:United States
D043373:Follicle Stimulating Hormone, Human; D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone